U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C50H69N15O9
Molecular Weight 1024.178
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MELANOTAN II

SMILES

CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CN=CN5)NC1=O)C(N)=O

InChI

InChIKey=JDKLPDJLXHXHNV-MFVUMRCOSA-N
InChI=1S/C50H69N15O9/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56)/t35-,36-,37-,38+,39-,40-,41-/m0/s1

HIDE SMILES / InChI

Molecular Formula C50H69N15O9
Molecular Weight 1024.178
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 16:57:20 GMT 2023
Edited
by admin
on Sat Dec 16 16:57:20 GMT 2023
Record UNII
UPF5CJ93X7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MELANOTAN II
Common Name English
MT-II
Common Name English
(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide
Systematic Name English
Melanotan II [WHO-DD]
Common Name English
L-LYSINAMIDE, N-ACETYL-L-NORLEUCYL-L-.ALPHA.-ASPARTYL-L-HISTIDYL-D-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-, CYCLIC (2->7)-PEPTIDE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-Melanotan II
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
Code System Code Type Description
FDA UNII
UPF5CJ93X7
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
CAS
121062-08-6
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
IUPHAR
1323
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
WIKIPEDIA
Melanotan_II
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
EPA CompTox
DTXSID90153135
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
PUBCHEM
92432
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
SMS_ID
100000134768
Created by admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Ki
TARGET -> AGONIST
Sexual effects are thought to be related to its ability to activate the MC4 receptor (though the MC3 is thought to also possibly be involved).
Ki
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
Melanotan II produces melanogenesis by activation of the MC1 receptor.
Ki
TARGET -> AGONIST
TARGET -> AGONIST
Binding Assay
IC50
Related Record Type Details
ACTIVE MOIETY